Literature DB >> 10084295

Toxicity of parenteral iron dextran therapy.

D L Burns1, J J Pomposelli.   

Abstract

Parenteral iron dextran is efficacious and safe for iron repletion in patients with iron-deficiency anemia. The risk for developing reactions to parenteral iron infusion can be attenuated if patients are carefully selected. Patients with underlying autoimmune disease, malnutrition with indolent infection, and risk for iron overload syndromes should be carefully monitored for complications. Further, the rate of infusion and the route of administration of iron dextran play roles in the risk of adverse reactions. The purpose of this review is to identify and elucidate the mechanisms of the acute and chronic toxicities associated with parenteral iron dextran use.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10084295     DOI: 10.1046/j.1523-1755.1999.055suppl.69119.x

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  10 in total

1.  Parenteral iron formulations differentially affect MCP-1, HO-1, and NGAL gene expression and renal responses to injury.

Authors:  Ali C M Johnson; Kirsten Becker; Richard A Zager
Journal:  Am J Physiol Renal Physiol       Date:  2010-05-26

Review 2.  Clinical Translation of Nanomedicine.

Authors:  Yuanzeng Min; Joseph M Caster; Michael J Eblan; Andrew Z Wang
Journal:  Chem Rev       Date:  2015-06-19       Impact factor: 60.622

Review 3.  A Review of Clinical Translation of Inorganic Nanoparticles.

Authors:  Aaron C Anselmo; Samir Mitragotri
Journal:  AAPS J       Date:  2015-05-09       Impact factor: 4.009

Review 4.  Prevention and management of acute reactions to intravenous iron in surgical patients.

Authors:  Susana Gómez-Ramírez; Aryeh Shander; Donat R Spahn; Michael Auerbach; Giancarlo M Liumbruno; Stefania Vaglio; Manuel Muñoz
Journal:  Blood Transfus       Date:  2018-10-16       Impact factor: 3.443

5.  Systemic iron supplementation replenishes iron stores without enhancing colon carcinogenesis in murine models of ulcerative colitis: comparison with iron-enriched diet.

Authors:  Darren N Seril; Jie Liao; Chung S Yang; Guang-Yu Yang
Journal:  Dig Dis Sci       Date:  2005-04       Impact factor: 3.199

Review 6.  [Indications and practical management of parenteral iron therapy].

Authors:  Markus Kosch; Roland M Schaefer
Journal:  Wien Klin Wochenschr       Date:  2003-06-24       Impact factor: 1.704

Review 7.  Modern iron replacement therapy: clinical and pathophysiological insights.

Authors:  Domenico Girelli; Sara Ugolini; Fabiana Busti; Giacomo Marchi; Annalisa Castagna
Journal:  Int J Hematol       Date:  2017-12-01       Impact factor: 2.490

8.  Study of individual erythrocyte deformability susceptibility to INFeD and ethanol using a microfluidic chip.

Authors:  Lihong Liu; Sha Huang; Xiaoying Xu; Jongyoon Han
Journal:  Sci Rep       Date:  2016-03-11       Impact factor: 4.379

Review 9.  Iron deficiency anaemia in pregnancy and postpartum: pathophysiology and effect of oral versus intravenous iron therapy.

Authors:  Alhossain A Khalafallah; Amanda E Dennis
Journal:  J Pregnancy       Date:  2012-06-26

10.  Randomized double-blind safety comparison of intravenous iron dextran versus iron sucrose in an adult non-hemodialysis outpatient population: A feasibility study.

Authors:  Martha L Louzada; Cyrus C Hsia; Fatimah Al-Ani; Fiona Ralley; Anargyros Xenocostas; Janet Martin; Sarah E Connelly; Ian H Chin-Yee; Leonard Minuk; Alejandro Lazo-Langner
Journal:  BMC Hematol       Date:  2016-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.